Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: A double-blind, randomized, placebo-controlled, and dose-ranging trial
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 54 of the 54 references it cites were found in a registry or an index.
Abstract
CFU of HN019/day for constipation. A total of 228 adults who were diagnosed with functional constipation according to the Rome III criteria were randomized in a double-blind and placebo-controlled trial. Colonic transit time (CTT), the primary outcome, and secondary outcomes that were measured using inventories-patient assessment of constipation symptoms (PAC-SYM) and quality of life (PAC-QoL), bowel function index (BFI), bowel movement frequency (BMF), stool consistency, degree of straining, bowel emptying, bloating, and pain severity-were assessed. Ancillary parameters and harms were also evaluated. There were no statistically significant differences in the primary or secondary outcomes between interventions. A post hoc analysis of 65 participants with fewer than 3 bowel movements per week (BMF ≤ 3/week) showed a physiologically relevant increase in weekly BMF in the high- (+2.0) and low-dose (+1.7) HN019 groups-by RMANOVA, the HN019 groups with BMF ≤ 3/week, pooled together, had a higher BMF versus placebo (P value = 0.01). Thus, improving low stool frequency could be a target of future interventions with HN019. High-dose HN019 also decreased the degree of straining at Day 28 versus placebo in those with BMF ≤ 3/week (P value = 0.02). Three unlikely related AEs-2 with low-dose HN019 and 1 with placebo-were followed until full recovery. In conclusion, although there were no differences in the primary analysis, HN019 is well tolerated and improves BMF in adults with low stool frequency.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Bifidobacterium animalis subsp lactis HN019 (HN019) has been shown to improve constipation and gastrointestinal tract symptoms in adults at doses ranging from 1.0 × 109 to 17.2 × 109 colony-forming units (CFU)/d for 2 to 4 weeks.5,6”
From Eight-Week Supplementation With Bifidobacterium lactis HN019 and Functional Constipation: A Randomized Clinical Trial (2024) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This increase in the placebo group is in line with what was observed earlier for the placebo group in the ITT population of Ibarra and coworkers5 and is likely a placebo effect.”
From Eight-Week Supplementation With Bifidobacterium lactis HN019 and Functional Constipation: A Randomized Clinical Trial (2024) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“HN019, the strain investigated in the present study, has been reported to improve BMF in people with constipation.5,6”
From Eight-Week Supplementation With Bifidobacterium lactis HN019 and Functional Constipation: A Randomized Clinical Trial (2024) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The Rome III criteria for functional constipation require a minimum of 2 of 5 criteria to be met for diagnosis, introducing the potential for substantial heterogeneity in a study population.5”
From Eight-Week Supplementation With Bifidobacterium lactis HN019 and Functional Constipation: A Randomized Clinical Trial (2024) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The results of the primary outcome (CSBMs per week) contrast with earlier reports.5,6”
From Eight-Week Supplementation With Bifidobacterium lactis HN019 and Functional Constipation: A Randomized Clinical Trial (2024) · cites this paper as [5]
Experimental — accuracy not yet measured
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
the CONSORT Group, Schulz, K. F., Altman, D. G., & Moher, D. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-18 · Cited by 13,371
Cook, R. J., Dickens, B. M., & Fathalla, M. F. (2003) · Reproductive Health and Human Rights · doi:10.1093/acprof:oso/9780199241323.003.0025 · Cited by 10,769
The functional gastrointestinal disorders and the Rome III process
Drossman, D. A. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.03.008 · Cited by 2,416
CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials
Schulz, K. F., Altman, D. G., & Moher, D. (2010) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.72352 · Cited by 2,165
Hagströmer, M., Oja, P., & Sjöström, M. (2006) · Public Health Nutrition · doi:10.1079/phn2005898 · Cited by 1,958 · cited 1×
“On Days 0 and 28, the short version of the International Physical Activity Questionnaire (IPAQ) was answered.(22) Before the visits on Days 0 and 28, they supplied their 24-h food recall—total calories (Kcal), total carbohydrates (g and %Kcal), total lipids (g and %Kcal), total proteins (g and %Kcal), alcohol (g and %…”
MethodBetter Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement
Ioannidis, J. P. A., Evans, S. J. W., Gøtzsche, P. C., O'Neill, R. T., Altman, D. G., Schulz, K., Moher, D., & for the CONSORT Group* (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-10-200411160-00009 · Cited by 1,593 · cited 1×
“The study has been reported per the CONSORT statement.(19,20)”
MethodThe Medical Dictionary for Regulatory Activities (MedDRA)
Brown, E. G., Wood, L., & Wood, S. (1999) · Drug Safety · doi:10.2165/00002018-199920020-00002 · Cited by 1,390
Suares, N. C., & Ford, A. C. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.164 · Cited by 904 · cited 1×
“Chronic idiopathic constipation, a gastrointestinal (GI) disorder of colonic or anorectal function, affects 14% of the population worldwide.(1) Historically, health care professionals have defined constipation as fewer than 3 bowel movements per week.”
BackgroundFord, A. C., Quigley, E. M. M., Lacy, B. E., Lembo, A. J., Saito, Y. A., Schiller, L. R., Soffer, E. E., Spiegel, B. M. R., & Moayyedi, P. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.202 · Cited by 747
Defecation frequency and timing, and stool form in the general population: a prospective study.
Heaton, K. W., Radvan, J., Cripps, H., Mountford, R. A., Braddon, F. E., & Hughes, A. O. (1992) · Gut · doi:10.1136/gut.33.6.818 · Cited by 733 · cited 1×
“7) is meaningful and physiological relevant.(2,37) As a reference, the use of laxatives and fiber can lead to an overall increase of approximately 1.”
BackgroundRome III: New standard for functional gastrointestinal disorders.
Drossman, D. A., & Dumitrascu, D. L. (2006) · PubMed · Cited by 660
Development and validation of the Patient Assessment of Constipation Quality of Life questionnaire
Marquis, P., De La Loge, C., Dubois, D., McDermott, A., & Chassany, O. (2005) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520510012208 · Cited by 584 · cited 1×
“However, its accuracy as a clinical tool has been debated, due to its inadequacy in properly differentiating certain disorders—eg, between functional constipation and irritable bowel syndrome(49)—and its lack of sensitivity in detecting meaningful changes in response to treatment strategies over time.(8) In our study,…”
BackgroundPsychometric Validation of a Constipation Symptom Assessment Questionnaire
L. Frank, L. K. (1999) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655299750025327 · Cited by 458
Oral bisacodyl is effective and well-tolerated in patients with chronic constipation
Kamm, M. A., Mueller–Lissner, S., Wald, A., Richter, E., Swallow, R., & Gessner, U. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.03.026 · Cited by 257
Saad, R. J., Rao, S. S., Koch, K. L., Kuo, B., Parkman, H. P., McCallum, R. W., Sitrin, M. D., Wilding, G. E., Semler, J. R., & Chey, W. D. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.612 · Cited by 248 · cited 1×
“7 bowel movements per week.(36) However, we expected little improvement in BSS, given that non-constipated healthy adults report a weekly stool score of 3.”
BackgroundProofs that really count: the art of combinatorial proof
(2004) · Choice Reviews Online · doi:10.5860/choice.41-4086 · Cited by 226 · cited 1×
“For example, a standard combination analysis—in which 6 criteria (n) choose 2 criteria (k)—shows that 15 subgroups (or subpopulations) are possible.(50) Therefore, the result is a mixture of several subpopulations, collectively defined as ‘functional constipation’ per Rome III, creating a lack of homogeneity that coul…”
BackgroundMueller-Lissner, S., Kamm, M. A., Wald, A., Hinkel, U., Koehler, U., Richter, E., & Bubeck, J. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.41 · Cited by 218
Camilleri, M., Thorne, N. K., Ringel, Y., Hasler, W. L., Kuo, B., Esfandyari, T., Gupta, A., Scott, S. M., Mccallum, R. W., Parkman, H. P., et al. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01517.x · Cited by 209
Wong, R. K., Palsson, O. S., Turner, M. J., Levy, R. L., Feld, A. D., von Korff, M., & Whitehead, W. E. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.200 · Cited by 204
Waller, P. A., Gopal, P. K., Leyer, G. J., Ouwehand, A. C., Reifer, C., Stewart, M. E., & Miller, L. E. (2011) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2011.584895 · Cited by 195 · cited 4×
“Overall, males had shorter CTTs than females, as expected.26 The CTT of the entire population at baseline (64 h) is consistent with previous studies that enrolled participants per Rome III criteria.27-29 Waller et al. reported significant reductions in CTT that were induced by HN019 dosedependently (decreases of 28.1…”
BackgroundResultInfluentialSelf-citationOuwehand, A. C., Lagström, H., Suomalainen, T., & Salminen, S. (2002) · Annals of Nutrition and Metabolism · doi:10.1159/000063075 · Cited by 185 · cited 1×
“to alter the GI microflora,(12) improve intestinal motility, and alter biochemical factors.(13) These properties have been observed with Lactobacillus and Bifidobacterium species,(12) and several traits of Bifidobacterium animalis subsp.”
BackgroundSelf-citationEfficacy of a Chinese Herbal Proprietary Medicine (Hemp Seed Pill) for Functional Constipation
Cheng, C.-W., Bian, Z.-X., Zhu, L.-X., Wu, J. C. Y., & Sung, J. J. Y. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.305 · Cited by 174
The Treatment of Chronic Constipation in Adults A Systematic Review
Tramonte, S. M., Brand, M. B., Mulrow, C. D., Amato, M. G., O'Keefe, M. E., & Ramirez, G. (1997) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.1997.12103.x · Cited by 170
Bristol scale stool form. A still valid help in medical practice and clinical research
Riegler, G., & Esposito, I. (2001) · Techniques in Coloproctology · doi:10.1007/s101510100019 · Cited by 168
Journal of Gastrointestinal and Liver Diseases
(2019) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld.2014.1121 · Cited by 164
(2013) · European Journal of Nutrition · doi:10.1007/394.1436-6215 · Cited by 160
The Treatment of Chronic Constipation in Adults: A Systematic Review
Tramonte, S. M., Brand, M. B., Mulrow, C. D., Amato, M. G., O'Keefe, M. E., & Ramirez, G. (1997) · Journal of General Internal Medicine · doi:10.1007/s11606-006-0003-5 · Cited by 159 · cited 3×
“8], which might be considered to be clinically significant.(2)”
BackgroundInfluence of age, gender, hormonal status and smoking habits on colonic transit time
Meier, R., BEGLINGER, C., DEDERDING, J. P., MEYER‐WYSS, B., FUMAGALLI, M., ROWEDDER, A., TURBERG, Y., & BRIGNOLI, R. (1995) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.1995.tb00231.x · Cited by 149 · cited 1×
“Overall, males had shorter CTTs than females, as expected.(26) The CTT of the entire population at baseline (64 h) is consistent with previous studies that enrolled participants per Rome III criteria.”
ResultMicka, A., Siepelmeyer, A., Holz, A., Theis, S., & Schön, C. (2017) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2016.1212819 · Cited by 139
Yiannakou, Y., Piessevaux, H., Bouchoucha, M., Schiefke, I., Filip, R., Gabalec, L., Dina, I., Stephenson, D., Kerstens, R., Etherson, K., et al. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.115 · Cited by 104
Waitzberg, D. L., Logullo, L., Bittencourt, A. F., Torrinhas, R. S., Shiroma, G. M., Paulino, N. P., & Teixeira-da-Silva, M. L. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2012.08.010 · Cited by 95
EFSA Panel on Dietetic Products, N. A. A. (. (2015) · EFSA Journal · doi:10.2903/j.efsa.2015.3951 · Cited by 89
Dupont, C., Campagne, A., & Constant, F. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.12.005 · Cited by 70
Probiotics in gastroenterology: indications and future perspectives
D., G., D., J., E., S., Bogaard, A. V. D., M., R., & R., S. (2003) · Scandinavian Journal of Gastroenterology · doi:10.1080/00855920310002645 · Cited by 68
Bothe, G., Coh, A., & Auinger, A. (2017) · European Journal of Nutrition · doi:10.1007/s00394-015-1094-8 · Cited by 57
Contemporary meta-analysis of short-term Probiotic consumption on gastrointestinal transit
Miller, L. E., Zimmermann, A. K., & Ouwehand, A. C. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i21.5122 · Cited by 57 · cited 1×
“Probiotics appear to have beneficial effects on chronic idiopathic constipation,(10) and a recent metaanalysis suggests that probiotic supplementation is moderately efficacious in decreasing intestinal transit times compared with control.(11) This activity has been proposed to be attributed to the capacity of probioti…”
BackgroundSelf-citationKang, D.-W., DiBaise, J. K., Ilhan, Z. E., Crowell, M. D., Rideout, J. R., Caporaso, J. G., Rittmann, B. E., & Krajmalnik-Brown, R. (2015) · Anaerobe · doi:10.1016/j.anaerobe.2015.01.005 · Cited by 55
Yeun, Y.-R., & Lee, J.-J. (2014) · Archives of Pharmacal Research · doi:10.1007/s12272-014-0522-2 · Cited by 53
Rentz, A. M., van Hanswijck de Jonge, P., Leyendecker, P., & Hopp, M. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.535270 · Cited by 53
Laxative Inadequate Relief Survey (LIRS) Group, Neri, L., Conway, P. M., & Basilisco, G. (2014) · Quality of Life Research · doi:10.1007/s11136-014-0886-2 · Cited by 51
Summary of Probiotic Activities of Bifidobacterium lactis HN019
Sanders, M. E. (2006) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000225576.73385.f0 · Cited by 49 · cited 1×
“lactis HN019 (HN019) have been studied with regard to its activity as a probiotic, such as its identity, safety, antipathogenic effects, immune enhancement, and intestinal colonization.(14)”
BackgroundSynbiotic preparation in men suffering from functional constipation: a randomised controlled trial
Fateh, R., Iravani, S., Frootan, M., Saadat, S., & Rasouli, M. (2011) · Swiss Medical Weekly · doi:10.4414/smw.2011.13239 · Cited by 46
Polymeros, D., Beintaris, I., Gaglia, A., Karamanolis, G., Papanikolaou, I. S., Dimitriadis, G., & Triantafyllou, K. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3135-1 · Cited by 42
Effect of Perineal Self-Acupressure on Constipation: A Randomized Controlled Trial
Abbott, R. B., Ayres, I., Hui, E., & Hui, K.-K. P. (2014) · Journal of General Internal Medicine · doi:10.1007/s11606-014-3084-6 · Cited by 31
Colonic response to food in constipation
Bouchoucha, M. L., Devroede, G. J., Faye, A., Toumelin, P. L., Arhan, P., & Arsac, M. (2005) · International Journal of Colorectal Disease · doi:10.1007/s00384-005-0787-5 · Cited by 25
Chinese herbal medicine for functional constipation: a randomised controlled trial.
Bian, Z., Cheng, C. W., & Zhu, L. (2013) · PubMed · Cited by 23
Miller, L. E. (2016) · Annals of Gastroenterology · doi:10.20524/aog.2016.0108 · Cited by 23 · cited 3×
“Participants from the ITT cohort who had had a BMF of 3 per week during the entire 14day run-in period were included in this population— as suggested by Miller et al.(25)—and are hereafter referred to as BMF 3/week.”
BackgroundMethodInfluentialIbarra, A., Pelipyagina, T., Rueffer, M., Evans, M., & Ouwehand, A. C. (2019) · Nutrients · doi:10.3390/nu11020439 · Cited by 22
Self-citationDa, N., Wang, X., Liu, H., Xu, X., Jin, X., Chen, C., Zhu, D., Bai, J., Zhang, X., Zou, Y., et al. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/670963 · Cited by 19
Self-reported Fecal Incontinence in a Community-Dwelling, Urban Population in Southern Brazil
Santos, V. L. C. D. G., Domansky, R. D. C., Hanate, C., Matos, D. S., Benvenuto, C. V. C., & Jorge, J. M. N. (2013) · Journal of Wound Ostomy and Continence Nursing · doi:10.1097/01.won.0000438018.83110.88 · Cited by 16
Relevance of Colonic Gas Analysis and Transit Study in Patients With Chronic Constipation
Park, S., Park, H.-B., Lee, J.-M., Lee, H., Park, C., Kim, H., Choi, S.-K., & Rew, J. (2015) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm14109 · Cited by 15
Dalziel, J. E., Anderson, R. C., Peters, J. S., Lynch, A. T., Spencer, N. J., Dekker, J., & Roy, N. C. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00020 · Cited by 14
Correcting for non-compliance when determining colonic transit time with radio-opaque markers
Ibarra, A., Olli, K., & Ouwehand, A. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i4.740 · Cited by 5 · cited 2×
“All participants consumed 100% of radio-opaque markers, so no adjustments were needed in the CTT calculations.(21) There were no significant differences in CTT between treatments in the ITT or BMF 3/week population (see Table 2).”
BackgroundMethodSelf-citation
Research works printed but not linked: 4
- WHO, Guidelines for ATC Classification, 1993, 23
- Miller LE, 2017, Annals of Gastroenterology, 30, 161
- Fateh R, 2010, Swiss medical weekly, 141, w13239
- Bian Z, 2013, Hong Kong medical journal = Xianggang yi xue za zhi/Hong Kong Academy of Medicine, 19, 44
Cited by
Clostridium species as probiotics: potentials and challenges
Guo, P., Zhang, K., Ma, X., & He, P. (2020) · Journal of Animal Science and Biotechnology · doi:10.1186/s40104-019-0402-1 · Cited by 597
World Gastroenterology Organisation Global Guidelines: Probiotics and Prebiotics
Guarner, F., Sanders, M. E., Szajewska, H., Cohen, H., Eliakim, R., Herrera-deGuise, C., Karakan, T., Merenstein, D., Piscoya, A., Ramakrishna, B., et al. (2024) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000002002 · Cited by 209
Lai, H., Li, Y., He, Y., Chen, F., Mi, B., Li, J., Xie, J., Ma, G., Yang, J., Xu, K., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2197837 · Cited by 208
Role of gut microbiota in functional constipation
Zhang, S., Wang, R., Li, D., Zhao, L., & Zhu, L. (2021) · Gastroenterology Report · doi:10.1093/gastro/goab035 · Cited by 175
Pan, R., Wang, L., Xu, X., Chen, Y., Wang, H., Wang, G., Zhao, J., & Chen, W. (2022) · Nutrients · doi:10.3390/nu14183704 · Cited by 149
Metadata
- Authors
- Ibarra, A., Latreille-Barbier, M., Donazzolo, Y., Pelletier, X., & Ouwehand, A. C.
- Affiliations
- DuPont (Finland) (FI)
- Eurofins Optimed SAS, Clinical Research, Gières, France
- Eurofins (France) (FR)
- Corresponding author
- Ibarra, Alvin
- Venue
- Gut Microbes
- Publisher
- Informa UK Limited
- Published
- 2018-02-08
- Volume
- 9
- Issue
- 3
- Pages
- 236-251
- ISSN
- 1949-0976 (ISSN-L)
- 1949-0984
- PMC
- PMC6219592
- OpenAlex
- W2773593508
- Cited by
- 121
- References
- 53
- Citations by year
- 2026: 14 · 2025: 15 · 2024: 26 · 2023: 17 · 2022: 17 · 2021: 10 · 2020: 11 · 2019: 9 · 2018: 1
- FWCI
- 6.32
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Gut Microbes (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- DuPont
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- functional constipation, colonic transit time, probiotic supplementation, stool frequency, straining, stool consistency, quality of life, dose-ranging, adverse events
- MeSH terms
- Bifidobacterium animalis, Adolescent, Adult, Aged, Constipation, Double-Blind Method, Female, Gastrointestinal Transit, Humans, Male, Middle Aged, Placebos, Quality of Life, Treatment Outcome, Probiotics, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.